Updated:
Bioventus
Bioventus is an asset manager based in Durham, founded 2012; the Altss profile covers its classification, headquarters, registration, AUM band, and key...
Overview
Bioventus products, orthobiologics, biologics and devices for bone healing and osteoartritis pain relief are known as innovations for active healing.
General information
Firm type
Asset Manager
Year founded
2012
Location
Region
North America
Country
United States
City
Durham
Corporate office
Durham, NC, United States
Additional offices
Memphis, TN; Valencia, CA; Farmingdale, NY; Mississauga, Ontario, Canada; Hoofddorp, Netherlands
Principals
Robert Claypoole
CEO
Sector focus
Frequently asked questions
Who runs investment decisions at Bioventus?
CEO Robert Claypoole leads the executive team; strategic decisions on capital allocation — including acquisitions, divestitures, and R&D investment — are made by the board of directors and reported quarterly (per SEC filings).
How does Bioventus source proprietary deal flow?
Bioventus pursues a combined strategy of internal product development, product/business acquisition, and distribution agreements. It has made notable acquisitions such as the Misonix ultrasonic platform in 2021 and asset purchases from the bankrupt Nuvasive spine business, adding bone graft substitutes.
Does Bioventus participate in fund commitments or only direct deals?
Bioventus invests directly in product development and acquisitions — it does not commit capital to external funds as a limited partner.
Which sectors does Bioventus explicitly avoid?
Bioventus restricts itself to orthobiologics, surgical devices, and pain treatments — it does not develop pharmaceuticals, diagnostics, or non-orthopedic implants.
What is Bioventus' known posture on co-investments alongside external GPs?
Bioventus does not engage in co-investments with external general partners — its capital allocation is focused on its own product portfolio and M&A.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: